September 21, 2021
SAN FRANCISCO, Sept. 21, 2021 /PRNewswire/ — Molekule, the global leader in reinventing air purification, today announced test results in collaboration with the University of Nebraska Medical Center, Department of Pharmacology & Experimental Neuroscience, which demonstrate its PECO air purification technology’s success in removing 99.98% of the COVID-19 virus SARS-CoV-2 from the air, and total destruction rates exceeding 99%. These results are from a multiple pass chamber test and swatch level test, respectively. The multiple pass chamber test utilized an Air Mini device in a small chamber with a single injection of virus aerosol, and the swatch level test used PECO filter media. These results build on other peer-reviewed and published validation of Molekule’s proprietary PECO technology from the University of Minnesota, in which the company demonstrated the inactivation of coronavirus strains (bovine and porcine) and the H1N1 flu virus.
“My team’s testing focused on determining Molekule’s ability to capture and destroy SARS-CoV-2, specifically the strain isolated from Wisconsin,” said Dr. Siddappa Byrareddy, a Professor and Vice-Chair of Research in the Department of Pharmacology & Experimental Neuroscience at the University of Nebraska Medical Center, and the lead researcher on this study. Read rest here.